Journal of Natural Products
ARTICLE
Cisplatin was used as the positive control. 8R-Hydroxylabda-
13(16),14-dien-19-yl-cis-4-hydroxycinnamate and sequirin C
showed moderate cytotoxicity against HL-60, with IC50 values
of 14.3 and 5.5 μM, respectively, while cisplatin gave IC50 values of
2.0 μM. The other compounds were inactive (IC50 values >40 μM).
Metaseglyptorin A (1): colorless plates (MeOH); mp 140-142 °C;
[R]2D5 þ29.6 (c 0.41, CHCl3); UV (CHCl3) λmax (log ε) 239 (2.49), 235
(2.35), 229 (2.44), 217 (2.64), 198 (2.84) nm; IR (KBr) νmax 3441,
2959, 2933, 2871, 1709, 1642, 1460, 1375, 1192, 1034 cm-1; 1H and 13
C
NMR data, see Table 1; positive FABMS m/z 487 [M þ H]þ; positive
HRFABMS m/z 487.4163 [M þ H]þ (calcd for C32H55O3, 487.4151).
Metasequoic Acid C (2): colorless gum; [R]2D5 þ20.5 (c 0.30,
CHCl3); UV (CHCl3) λmax (log ε) 240 (3.35), 222 (2.71), 217
(2.73) nm; IR (KBr) νmax 3440, 2930, 1692, 1641, 1463, 1384, 1247,
1157 cm-1; 1H and 13C NMR data, see Table 2; positive EIMS m/z 320
[M]þ; positive HREIMS m/z 320.2356 [M]þ (calcd for C20H32O3,
320.2351).
’ EXPERIMENTAL SECTION
General Experimental Procedures. Melting points were ob-
tained on an X-4 micro melting point apparatus. Optical rotations were
measured on a JASCO-20C digital polarimeter. IR spectra were obtained
on a Tensor 27 spectrometer with KBr pellets. UV spectra were recorded
using a Shimadzu UV-2401A spectrophotometer. 1D and 2D NMR
spectra were performed on Bruker AM-400, DRX-500, or AVANCE III-
600 spectrometers with TMS as an internal standard. Mass spectra were
taken on VG Auto Spec-3000 or API-Qstar-Pulsar instruments. Semi-
preparative HPLC was performed on an Agilent 1100 liquid chromato-
graph with a Zorbax SB-C18 (9.4 mm ꢀ 25 cm) column. Column chro-
matography (CC) was performed using silica gel (100-200 and 200-
300 mesh, Qingdao Marine Chemical Co. Ltd., Qingdao, People’s
Republic of China), MCI gel (75-150 μm; Mitsubishi Chemical Corpora-
tion, Japan), and Sephadex LH-20 (Amersham Pharmacia Biotech,
Sweden).
12R-Hydroxy-8,15-isopimaradien-18-oic acid (3): colorless gum;
[R]2D5 þ135.6 (c 0.09, CHCl3); UV (CHCl3) λmax (log ε) 240 (3.01),
227 (2.78), 204 (2.88), 198 (2.90) nm; IR (KBr) νmax 3432, 2957, 2927,
1696, 1640, 1466, 1377, 1252 cm-1; 1H and 13C NMR data, see Table 2;
positive ESIMS m/z 341 [M þ Na]þ; positive HRESIMS m/z 341.2091
[M þ Na]þ (calcd for C20H30O3Na, 341.2092).
(-)-Acora-2,4(14),8-trien-15-oic acid (4): colorless gum; [R]D25
-
59.2 (c 0.32, CHCl3); UV (CHCl3) λmax (log ε) 241 (3.60), 231 (3.11),
222 (3.14), 212 (3.10), 203 (3.10) nm; IR (KBr) νmax 3440, 2960, 1689,
1640, 1423, 1273 cm-1; 1H and 13C NMR data, see Table 2; positive
ESIMS m/z 233 [M þ H]þ; positive HRESIMS m/z 233.1538 [M þ H]þ
(calcd for C15H21O2, 233.1541).
Plant Material. Stems and leaves of M. glyptostroboides were
collected in the Kunming Botany Garden, Kunming, Yunnan Province,
People’s Republic of China, in May 2009, and were identified by one of
the authors (X.G.). A voucher specimen (200905M) was deposited with
the State Key Laboratory of Phytochemistry and Plant Resources in West
China, Kunming Institute of Botany, Chinese Academy of Sciences.
Extraction and Isolation. The air-dried and powdered stems and
leaves of M. glyptostroboides (19 kg) were extracted with 95% EtOH (3 ꢀ
70 L), each for 48 h, at room temperature, and concentrated in vacuo.
The crude extract was partitioned between H2O and EtOAc. The EtOAc
portion (436 g) was decolorized on MCI gel (eluted with 90% MeOH)
and then was chromatographed on a silica gel column (100-200 mesh)
eluting with a gradient of petroleum ether-acetone (1:0, 9:1, 8:2, 7:3,
3:2, and 0:1) to afford six fractions (A-F). Fraction C (21 g) was
fractionated by MPLC (MCI) eluting with MeOH-H2O (from 30% to
100%) to provide subfractions (C1-C3). Subfraction C2 was recrystal-
lized to afford 3-acetoxylabda-8(20),13-dien-15-oic acid (5 g). Subfrac-
tion C3 was chromatographyed over Sephadex LH-20 eluted with
MeOH and then chromatographed repeatedly over silica gel, then by
semipreparative HPLC (83% MeOH-H2O), to give 4 (6 mg), 8R-
hydroxylabda-13(16),14-dien-19-yl cis-4-hydroxycinnamate (30 mg),
15,16-bisnor-13-oxo-8(17),11E-labdadien-19-oic acid (7 mg), and 8β-
hydroxy-isopimar-15-en-19-oic acid (20 mg). Fraction D (40.5 g) was
chromatographed on MPLC (MCI gel) (0:1 f 1:0, MeOH-H2O)
to give subfractions D1-D3. Compounds 2 (5 mg), 3 (1.8 mg), 12S,13R-
dihydroxylabda-8(17),14-dien-19-oic acid (3 mg), 12S,13S-dihydroxylabda-
8(17),14-dien-19-oic acid (4 mg), and 15-norlabda-8(20),12E-diene-
14-carboxaldehyd-19-oic acid (6 mg) were isolated from subfraction D1
by repeated chromatography including silica gel, MCI, and Sephadex LH-20.
3-Hydroxylabda-8(20),13-dien-15-oic acid (2 g) was crystallized from
subfraction D2 directly. Subfraction D3 was subjected to repeated silica
gel CC eluted with petroleum ether-acetone (9:1 f 0:1) and then by
semipreparative HPLC (69% MeOH-H2O) to obtain sequosempervirin D
(20 mg), agatharesinol acetonide (30 mg), and hinokiresinol (15 mg). The
acetone-insoluble part of fraction D (2 g) was chromatographed over
Sephadex LH-20 eluting with CHCl3-MeOH (1:1) and then by semipre-
parative HPLC (94% MeOH-H2O) to afford 1 (20 mg). Fraction E
(36.6 g) was submitted to repeated chromatography and purified
by Sephadex LH-20 and semipreparative HPLC to afford 5 (35 mg),
6 (12 mg), 7 (50 mg), sequosempervirin B (60 mg), sequosempervirin
F (45 mg), agatharesinol (20 mg), and sequirin C (50 mg).
Metasequirin D (5): colorless gum; [R]2D5 -40.5 (c 0.17, MeOH);
UV (MeOH) λmax (log ε) 269 (4.03), 204 (4.41), 194 (4.11) nm; IR
(KBr) νmax 3433, 1629, 1514, 1272, 1032 cm-1; 1H and 13C NMR data,
see Table 3; positive ESIMS m/z 369 [M þ Na]þ; positive HRESIMS
m/z 369.1317 [M þ Na]þ (calcd for C19H22O6Na, 369.1314).
Metasequirin E (6): colorless gum; [R]2D5 þ22.2 (c 0.25, MeOH);
UV (MeOH) λmax (log ε) 281(3.49), 229 (3.84), 204 (4.41) nm; IR
(KBr) νmax 3430, 1612, 1517, 1273, 1033 cm-1; 1H and 13C NMR data,
see Table 3; positive ESIMS m/z 385 [M þ Na]þ; positive HRESIMS
m/z 385.1272 [Ma þ Na]þ (calcd for C19H22O7Na, 385.1263).
Metasequirin F (7): colorless gum; [R]2D5 þ8.7 (c 0.32, MeOH); UV
(MeOH) λmax (logε) 279 (3.18), 226 (3.71), 204 (3.91), 193 (3.58) nm; IR
(KBr) νmax 3441, 1620, 1516, 1271, 1033 cm-1; 1H and 13C NMR data, see
Table 3; positive ESIMS m/z 355 [M þ Na]þ; positive HRESIMS m/z
355.1160 [M þ Na]þ (calcd for C18H20O6Na, 355.1157).
Methylation of the Phenolic OH Groups of 7. Diazomethane
in ether was added to a solution of 7 (8 mg, 24 μmol) in anhydrous
tetrahydrofuran (1 mL), which was stirred under N2 at room tempera-
ture overnight. The reaction mixture was concentrated under reduced
pressure, and the residue was purified by silica gel CC (petroleum ether-
acetone, 7:3) to afford 8 (8 mg, 100%): 1H NMR (400 MHz,
CD3COCD3) δ 3.27 (1H, m, H-7), 3.71, 3.73, and 3.74 (each 3H, s, -
OCH3), 3.80 (1H, dd, J = 9.1, 3.0 Hz, H-9b), 4.04 (1H, dd, J = 9.1,
4.8 Hz, H-9a), 4.16 (1H, m, H-8), 4.20 (1H, t, J = 4.8 Hz, H-80), 4.86
(1H, br s, H-70), 6.74 (2H, d, J = 8.5 Hz, H-3/5), 6.81 (1H, d, J = 8.5 Hz,
H-60), 6.89 (1H, dd, J = 8.5, 1.8 Hz, H-50), 6.94 (2H, d, J = 8.5 Hz, H-2/6),
6.98 (1H, d, J = 1.8 Hz, H-20).
Preparation of the (S)- and (R)-MTPA Esters of 8. A mixture
of 8 (2 mg, 5.5 μmol), (R)-MTPA (5 mg, 21.4 μmol, 3.9 equiv), DCC
(4 mg, 19.4 μmol, 3.5 equiv), and DMAP (2 mg, 16.4 μmol, 3.0 equiv)
was dissolved in anhydrous CH2Cl2 (0.5 mL), which was stirred under
N2 at room temperature for 24 h. The reaction mixture was concentrated
under reduced pressure, and the residue was purified by silica gel
CC (petroleum ether-acetone, 9:1) to yield bis-(R)-MTPA ester 9a
(1.5 mg). Bis-(S)-MTPA ester 9b (1.2 mg) was prepared in the same
manner.
Bis-(R)-MTPA Ester of 8 (9a): 1H NMR (600 MHz, CDCl3) δ 3.33
(1H, dd, J = 6.2, 4.8 Hz, H-7), 3.79 (1H, dd, J = 10.2, 3.0 Hz, H-9b), 4.26
(1H, dd, J = 10.2, 5.4 Hz, H-9a), 4.42 (1H, t, J = 6.2 Hz, H-80), 5.34
(1H, m, H-8), 5.84 (1H, d, J = 6.2 Hz, H-70), 6.55 (1H, d, J = 1.8 Hz,
238
dx.doi.org/10.1021/np100694k |J. Nat. Prod. 2011, 74, 234–239